Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Annual account missing NBB
Fiscal year 2025 was expected before 31 October 2025 and has not been filed.
Financials
Financial year 2024
D-PHARMA from Schaarbeek, company number BE0455755092, closed financial year 2024 with a result of € 34,289 after tax. For that financial year D-PHARMA recorded a gross margin of € 48,190 and equity of € 284,914. Compared with financial year 2023, the result moved from € 39,937 to € 34,289. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 28, 2024.
€ 284,914
▲ 3% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 34,289
▼ 14% vs 2023
Profit after tax over the fiscal year.
€ 35,515
▲ 154% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 25,000 paid out
73 % of the profit went to the shareholders, mostly to JEOZIF PHARMA (100 % of the shares). That is where the money ends up.
People and assets in 2024
€ 1,549
▼ 42% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 80,063
▲ 61% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 7,742
▲ 1% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|
| Gross margin | € 51,339 | € 49,321 | € 48,190 | ▼ 2% |
| Profit after taxes | € 42,826 | € 39,937 | € 34,289 | ▼ 14% |
| Equity | € 260,687 | € 275,625 | € 284,914 | ▲ 3% |
| Total debts | € 90,488 | € 87,344 | € 117,975 | ▲ 35% |
| Cash | € 17,737 | € 13,972 | € 35,515 | ▲ 154% |
| Retained profit | € 242,095 | € 257,033 | € 266,322 | ▲ 4% |
| Dividend | € 25,000 | € 25,000 | € 25,000 | |
| Balance sheet total | € 376,175 | € 387,969 | € 427,889 | ▲ 10% |
By gross margin, D-PHARMA ranks 37th of 47 companies with main activity “Detailhandel in farmaceutische producten” in Schaarbeek that publish figures (fiscal year 2024).
Key figures of D-PHARMA, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 October 2025.
Ask about D-PHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to D-PHARMA?
What happened at D-PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 34,289 (▼ 14% vs 2023). filed late Source: NBB ↗
- New establishment in Schaarbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 42,826 profit in 2022 to € 34,289 profit in 2024.
Paid € 18,824 in corporate taxes since 2022.
Best year ever: 2022, with € 42,826 profit.
Paid out € 75,000 in dividends to the owners in total.
Management
The stake of JEOZIF PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
D-PHARMABehind D-PHARMA is Jeozif Pharma. The shares are held by JEOZIF PHARMA (100%).
Directors
According to the 2024 annual accounts
Manager · represented by Jeozif Butros
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Jan Stobbaertslaan 10
1030 Schaarbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Schaarbeek
Same main activity (Detailhandel in farmaceutische producten), 49 active companies in Schaarbeek, largest first.
€ 16.9 million revenue · 2025
€ 1 million gross margin · 2025
€ 590,921 gross margin · 2025
€ 350,207 gross margin · 2025
€ 334,742 gross margin · 2024
€ 306,028 gross margin · 2025
Details
- Company number
- 0455.755.092
- VAT number
- BE 0455.755.092
- Registered office
- Jan Stobbaertslaan 10, 1030 Schaarbeek
- Names & denominations
- D-PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 July 1995
- Peppol
- Active · Active since 31 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers